Dr Dagmara Lewandowska works as a Product Manager at INTEGRA Biosciences, where she oversees introducing new products to the market, such as latest addition: MAGFLO™ magnetic beads for NGS size selection and PCR purification. With over a decade of experience, Dagmara specializes in customer-centric product development in laboratory automation, diagnostics and molecular biology applications across academia, diagnostics, and the biotech sector. As an accomplished scientist herself, she is a strong advocate for the power of NGS in advancing cutting-edge studies and she is dedicated to empowering researchers to accelerate their pioneering discoveries.
Cimeio Therapeutics is an applied gene editing and immunotherapy company developing a portfolio of Shielded-Cell & Immunotherapy Pairs™ (SCIP). To evaluate potential targets, explore new variants and optimize gene editing tools, Cimeio relies on flow cytometry and next generation sequencing (NGS) to determine editing accuracy, efficiency and shielding at both the cellular and genetic level.
The ASSIS Plus pipetting robot from Integra Biosciences has been integrated into the NGS workflow and has contributed to a more consistent, less time-consuming and less error-prone setup, resulting in an improvement of the overall quality of processing.
For conference production and speaking opportunites:
Für die Produktion von Konferenzen und die Möglichkeit, Vorträge zu halten:
For sponsorship and exhibition opportunities: